Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Nature

Volumn 453, Issue 7195, 2008, Pages 667-671

  Wrammert, Jens ^a   Smith, Kenneth ^c   Miller, Joe ^a   Langley, William A ^a   Kokko, Kenneth ^b   Larsen, Christian ^b   Zheng, Nai Ying ^c   Mays, Israel ^c   Garman, Lori ^c   Helms, Christina ^c   James, Judith ^c,d   Air, Gillian M ^d   Capra, J Donald ^c,d   Ahmed, Rafi ^a   Wilson, Patrick C ^c,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY; BLOOD; COMPARATIVE STUDY; HOMINID; IMMUNE RESPONSE; INFLUENZA; MUTATION; VACCINATION;

ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS; MEMORY CELL; MOLECULAR CLONING; PRIORITY JOURNAL; VIRUS STRAIN;

ORTHOMYXOVIRIDAE;

EID: 44449118948     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06890     Document Type: Article

References (28)

1. Francis, T. Jr. On the doctrine of original antigenic sin. Proc. Am. Phil. Soc. 104, 572-578 (1960).
2. Ahmed, R., Oldstone, M. B. & Palese, P. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nature Immunol. 8, 1188-1193 (2007).
3. Subbarao, K. & Joseph, T. Scientific barriers to developing vaccines against avian influenza viruses. Nature Rev. Immunol. 7, 267-278 (2007).
4. Gerhard, W. et al. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159, 95-103 (1997).
5. Luke, T. C., Kilbane, E. M., Jackson, J. L. & Hoffman, S. L. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann. Intern. Med. 145, 599-609 (2006).
6. Puck, J. M., Glezen, W. P., Frank, A. L. & Six, H. R. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J. Infect. Dis. 142, 844-849 (1980).
7. Simmons, C. P. et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 4, e178 (2007).
8. Bernasconi, N. L., Traggiai, E. & Lanzavecchia, A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298, 2199-2202 (2002).
9. Brokstad, K. A. et al. Parenteral influenza vaccination induces a rapid systemic and local immune response. J. Infect. Dis. 171, 198-203 (1995).
10. Brokstad, K. A. et al. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. J. Infect. Dis. 185, 878-884 (2002).
11. Sasaki, S. et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81, 215-228 (2007).
12. Poulsen, T. R. et al. Kinetic, affinity, and diversity limits of human polyclonal antibody responses against tetanus toxoid. J. Immunol. 179, 3841-3850 (2007).
13. Odendahl, M. et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105, 1614-1621 (2005).
14. Crotty, S., Aubert, R. D., Glidewell, J. & Ahmed, R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286, 111-122 (2004).
15. Koelsch, K. et al. Mature B cells class switched to IgD are autoreactive in healthy individuals. J. Clin. Invest. 117, 1558-1565 (2007).
16. Zheng, N. Y., Wilson, K., Jared, M. & Wilson, P. C. Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation. J. Exp. Med. 201, 1467-1478 (2005).
17. Zheng, N. Y. et al. Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. J. Clin. Invest. 113, 1188-1201 (2004).
18. Clarke, S. H. et al. Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J. Exp. Med. 161, 687-704 (1985).
19. Cook, W. D. & Scharff, M. D. Antigen-binding mutants of mouse myeloma cells. Proc. Natl Acad. Sci. USA 74, 5687-5691 (1977).
20. Meijer, P. J. et al. Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J. Mol. Biol. 358, 764-772 (2006).
21. Llewelyn, M. B., Hawkins, R. E. & Russell, S. J. Discovery of antibodies. Br. Med. J. 305, 1269-1272 (1992).
22. Crotty, S. et al. SAP is required for generating long-term humoral immunity. Nature 421, 282-287 (2003).
23. Webster, R., Cox, N. & Stohr, K. World Health Organization Manual on Animal Influenza Diagnosis and Surveillance (WHO, Geneva, 2002).
24. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
25. Crotty, S. et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171, 4969-4973 (2003).
26. Hartmann, G. et al. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164, 1617-1624 (2000).
27. Wilson, P. C. et al. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J. Exp. Med. 191, 1881-1894 (2000).
28. Stephenson, I. et al. Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res. 103, 91-95 (2004).